ArticleInvestigative ophthalmology & visual science2025
Plin2 Coordinates Immune and Metabolic Reprogramming in Lacrimal Gland Aging.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Aging impairs lacrimal gland function, contributing to dry eye syndrome and reduced quality of life. This study aimed to identify core molecular regulators of lacrimal gland aging and delineate their roles in immune imbalance and metabolic dysfunction. Methods: Bulk transcriptomic profiling and single-cell RNA sequencing (scRNA-seq) were performed on lacrimal glands from young and aged C57BL/6 mice. Differentially expressed genes (DEGs) were screened, followed by machine learning-based feature selection using least absolute shrinkage and selection operator regression and support vector machine-recursive feature elimination. Immune cell composition was inferred using the CIBERSORT algorithm, and functional enrichment (gene ontology, Kyoto Encyclopedia of Genes and Genomes, and gene set enrichment analysis) and cell-type-resolved spatial analyses were conducted to elucidate aging-associated pathways. Results: Among 659 DEGs, Perilipin-2 (Plin2) emerged as the sole hub gene identified by both algorithms, with perfect classification performance (area under the curve = 1.00). Aging was associated with increased infiltration of pro-inflammatory cells (naïve B cells, M1 macrophages) and depletion of anti-inflammatory subsets (plasma cells, M2 macrophages). Plin2 expression exhibited a significant inverse association with pro-senescent immune populations and a positive correlation with regulatory immune cells. Functional analyses linked Plin2 to T/B cell receptor signaling, cytokine interaction, and ribosomal biosynthesis. scRNA-seq revealed Plin2 downregulation in fibroblasts and Mono/Mφ/DC subsets in aged glands (P < 0.001), indicating stromal-immune dysfunction. Conclusions: Our study identifies Plin2 as a master regulator of immune-metabolic aging in the lacrimal gland. Its decline accelerates inflammaging and metabolic reprogramming, contributing to tissue atrophy and tear deficiency. Plin2 represents a promising candidate biomarker and potential therapeutic target for age-related ocular diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.